The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Genetic Testing at AdventHealth Alerts Woman, Doctors to Aggressive Cancer Before it Develops
-
AdventHealth Clinical Research Unit Recruiting Patients with Solid Tumors Harboring MTAP Deletion for Phase I Clinical Trial
-
AdventHealth Research Institute conducting two studies on the impact of shift work on healthcare workers’ health
-
AdventHealth Celebration Successfully Performs First Robotics-assisted Cochlear Implant Procedure in Florida with the iotaSOFT® Insertion System.
-
New England Journal of Medicine highlights Guru Sonpavde, MD’s work in new immunotherapy-chemotherapy combination improving survival for patients with advanced urothelial carcinoma
-
AdventHealth Celebration Team Performs First-in-World Procedure Targeting Kidney Tumor with Sound Beams
-
Creed Guitarist Mark Tremonti and AdventHealth for Children Pediatrician Discuss the Southeast’s First Lifespan Down Syndrome Clinic
-
AdventHealth Winter Garden Earns Certification as Center of Excellence in Hernia Surgery